On July 16, Definium Therapeutics rose 5.04% in after-hours trading, trading at $47.79 USD/share, with Turnover of $1.4192 million.
Within the Pharmacy sector where Definium Therapeutics belongs, among individual stocks, Eli Lilly up 0.02%, Johnson & Johnson up 0.39%, Merck up 0.02%, Pfizer down 0.16%, Bristol-Myers Squibb down 0.0%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)